Stereotaxis Stock Today
| STXS Stock | USD 2.32 0.06 2.52% |
PerformanceGood
| Odds Of DistressLow
|
Stereotaxis is selling for under 2.32 as of the 19th of July 2025; that is 2.52 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.29. Stereotaxis has about a 24 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 30th of July 2023 and ending today, the 19th of July 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 12th of August 2004 | Category Healthcare | Classification Health Care |
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri. The company has 86 M outstanding shares of which 3.54 M shares are at this time shorted by private and institutional investors with about 16.69 trading days to cover. More on Stereotaxis
Moving together with Stereotaxis Stock
| 0.8 | DH | Definitive Healthcare | PairCorr |
| 0.67 | EW | Edwards Lifesciences Corp Earnings Call This Week | PairCorr |
| 0.75 | LH | Laboratory Earnings Call This Week | PairCorr |
Moving against Stereotaxis Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Stereotaxis Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsStereotaxis can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Stereotaxis' financial leverage. It provides some insight into what part of Stereotaxis' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stereotaxis (STXS) is traded on NYSE MKT Exchange in USA. It is located in 710 North Tucker Boulevard, Saint Louis, MO, United States, 63101 and employs 139 people. Stereotaxis is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 204.68 M. Stereotaxis conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 86 M outstanding shares of which 3.54 M shares are at this time shorted by private and institutional investors with about 16.69 trading days to cover.
Stereotaxis currently holds about 30.94 M in cash with (8.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Check Stereotaxis Probability Of Bankruptcy
Ownership AllocationStereotaxis shows a total of 86 Million outstanding shares. Stereotaxis maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Stereotaxis Ownership Details
Stereotaxis Historical Income Statement
Stereotaxis Stock Against Markets
Stereotaxis Corporate Management
| Nathan Kastelein | RD Concepts | Profile | |
| John Platt | Director Software | Profile | |
| Brian Kidd | RD Devel | Profile | |
| Patricia Esq | General Secretary | Profile | |
| Laura Garth | General Secretary | Profile | |
| Keith Galloway | Vice Operations | Profile |
Additional Tools for Stereotaxis Stock Analysis
When running Stereotaxis' price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.